Position
Chief Medical Officer
Company
Innate Pharma
Description
Innate Pharma announced the appointment of Markus Jensen as Chief Medical Officer and member of the Executive Leadership Team. This appointment is effective September 1, 2026 and follows the company's strategic partnership with Sobi.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Percheron Therapeutics Appoints Michael Baker as Chief Executive Officer (August 10, 2026)
- City Therapeutics Appoints Keith Regnante as Chief Financial Officer and Mary Beth DeLena as Chief Legal Officer (August 11, 2026)
- Kalohexis Appoints Jeffrey Sherman as Chief Medical Officer (August 11, 2026)
- EIT Pharma Appoints Dr. Leen Kawas as Chief Executive Officer (August 12, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer (August 14, 2026)
Who to call at Innate Pharma, and when
A new leader at Innate Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Innate Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Innate Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Innate Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Innate Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Innate Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.